|
|
|
|
|
|
Regulus Therapeutics (RGLS)
|
|
1.02 +0.10 (+11.48%)
|
6/26/2017 4:00pm
|
|
Open:
|
0.94
|
Pre. Close:
|
0.92
|
|
High:
|
1.04
|
Low:
|
0.92
|
|
Volume:
|
738,606
|
Market Cap:
|
54.25M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.06 - 1.08
|
1.08 - 1.11
|
|
Low:
|
0.87 - 0.89
|
0.89 - 0.92
|
|
Close:
|
0.98 - 1.01
|
1.01 - 1.05
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-26 11:36:11 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 1.54 One year: 1.87
|
|
Support:
|
Support1: 0.86 Support2: 0.72
|
|
Resistance:
|
Resistance1:
1.32 Resistance2: 1.60
|
|
Pivot:
|
1.17 
|
|
Moving Averages:
|
MA(5): 0.96 MA(20): 1.23
MA(100): 1.36 MA(250): 2.33
|
|
MACD:
|
MACD(12,26):
-0.14 Signal(12,26,9): -0.12
|
|
%K %D:
|
%K(14,3): 15.54 %D(3): 13.86
|
|
RSI:
|
RSI(14): 38.13
|
|
52-Week:
|
High: 5.75
Low: 0.86 Change(%): -80.7
|
|
Average Vol(K):
|
3-Month: 856
10-Days 1207
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.RGLS has closed above bottom band by 34.6%. Bollinger Bands are 59.1% wider than normal. The large width of the bands suggest high volatility as compared to RGLS's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Mon, 26 Jun 2017 18:22:30 GMT
Another motive To buy these stock: Regulus Therapeutics Inc. (RGLS), Ollie's ...
Mon, 12 Jun 2017 10:52:30 GMT
Regulus Announces Pipeline Updates and Advancements
Mon, 26 Jun 2017 21:30:03 GMT
Regulus Therapeutics Inc. (RGLS) Soars 11.48% on June 26
Thu, 08 Jun 2017 06:00:00 GMT
Aptuit anuncia un acuerdo de proveedor estratégico con Regulus Therapeutics
Thu, 04 May 2017 20:26:15 GMT
BRIEF-Regulus reports Q1 revenue $100000
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
